This study evaluates the analytical performance of the Elecsys PIVKA-II immunoassay to aid in HCC diagnosis, establish method-specific reference ranges in healthy individuals, and perform a method comparison versus commercially available platforms under routine laboratory conditions.
Chan HLY, Vogel A, Berg T, De Toni EN, Kudo M, Trojan J, Weinmann A, Eiblmaier A, Klein HG, Hegel JK, Morgenstern D, Madin K, Rolny V, Lisy MR, Piratvisuth T…
Cancer Type: Liver
Analytical performance and method comparison of the Elecsys PIVKA-II immunoassay as an aid in diagnosis of hepatocellular carcinoma (HCC)
A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort
This study compared the clinical performance of the Elecsys GALAD (gender [sex], age, alpha-fetoprotein [AFP] Lens culinaris agglutinin-reactive fraction of AFP [AFP-L3] and protein-induced by vitamin K absence-II [PIVKA-II]) and Elecsys GAAD (gender [sex], age, AFP and PIVKA-II) algorithms in differentiating hepatocellular carcinoma and benign chronic liver disease.
Chan HLY, Vogel A, Berg T, De Toni EN, Kudo M, Trojan J, Malinowsky K, Findeisen P, Klein HG, Hegel JK, Schƶning W, Krƶniger K, Madin K, Sharma A, Piratvisuth T
…
Hepatocellular carcinoma – the āsilent killerā disease infographic
Chronic liver disease (CLD) is on the rise. CLD can progress to Hepatocellular Carcinoma (HCC), a type of liver cancer. What are the risk factors for HCC, and how is it diagnosed and treated? Read this infographic to find out more. …
Hepatocellular carcinoma ā the āsilent killerā | Part 2
How did Taiwan halve the incidence of hepatocellular carcinoma (HCC) in a decade? HCC is the primary form of liver cancer, with 72% of cases diagnosed in Asia. Find out about the challenges people with HCC face, and what can be done to improve outcomes….
Hepatocellular carcinoma ā the āsilent killerā | Part 1
Do you know what can cause hepatocellular carcinoma, the primary form of liver cancer? In Asia, contaminated food has historically been linked with the disease and hepatitis B and C continue to be a major risk factor. Find out more about these risk factors and others that are linked with liver cancer….
Liver cancer: the global impact
Hepatocellular carcinoma numbers continue to rise globally, due to major risk factors such as Hepatitis B and C, and fatty liver disease. Hear Liver Patients Internationalās co-founder George Kalamitsis and liver cancer expert Dr Toh Han Chong discussing this major public health issue….